Singlemalt
Well-Known Member
I handle my liquor quite well, hence I'm still alive. Since I stopped drinking tequila, others are as well
What are you seeing??
- Thread starter MICHI-CAN
- Start date
You build better immunity to the flu by catching it than taking the vaccine. However you reach a point of diminishing returns as you age. I'm curious to see if they can develop a vaccine for the corona virus or if we will go on the annual best estimate of it's mutations as we do with the flu. But I digress.
DwayneWayne
Well-Known Member
I freaking hope so and I must admit that it took me more than a minute to realize golf and basketball today was re-runs.
Singlemalt
Well-Known Member
If my daugter gets off her ass and finishes her thesis, we may see a one time on the button flu vacc
MICHI-CAN
Well-Known Member
Same move same result.
MICHI-CAN
Well-Known Member
We unfortunately are enslaved a to system that only treats symptoms and provides limited protection. Profit in making you feel better. None in making you better.
DwayneWayne
Well-Known Member
Well you shouldn't because theres a slight chance I gained 1 IQ point from reading your post through some e-osmosis hoodoo.
I hope so. We could use a light at the end of the tunnel that's not just another train.
doublejj
Well-Known Member
Interesting evolution
doublejj
Well-Known Member
Kassiopeija
Well-Known Member
well, like you wrote "its just another corona virus"... these are RNA viruses which are much less stable than DNA viruses
doublejj
Well-Known Member
pretty hard to tell who the "victims" are if you haven't tested for it.....they are saving the tests for the living and health care workers...
Luckily it appears there's a similar homology in B and T cell epitopes between SARS-CoV and SARS-CoV-2. This is a good article if you're interested.
N.B. a lot of what I say in TnT is in jest.
Kassiopeija
Well-Known Member
thank you, that was a difficult but enormous informative read. However, this is alarming:
"Because of the overall high level of sequence similarity of SARS-CoVand SARS-CoV-2, we infer that the regions dominant in SARS-CoV have a high likelihood to also be dominant in SARS-CoV-2, even if the actual sequences are different. This hypothesis is in agreement with the recent cryoEM structure of the spike glycoproteinof SARS-CoV-2, showing a high resemblance in the overall structure with the SARS-CoV spike protein (Wrapp et al., 2020). In the same study, however, the authors do not observe cross-recognition of SARS-CoV monoclonal antibodies with the SARS-CoV-2. Indeed, they observed no reactivity with SARS-CoV antibodies that recognize the SARS-CoV-2 spike receptor binding domain (RBD), despite the fact that SARS-CoV-2 retain the same capability to bind the ACE2 receptor of SARS-CoV (Wrapp et al., 2020). This suggests that the B cell prediction performed on the RBD domain will require further studies."
The study also seems to suggest that scientists do currently not know - and are unable to extract - the specific antibodies relevant to neutralize SARS-CoV-2....
Similar threads
